Henan Taloph Pharmaceutical Stock Co Ltd. Stock Analysis 600222.SS

Henan Taloph Pharmaceutical Stock Co., Ltd. engages in the research, development, production and sale of Chinese patent medicines and Western medicines. The company is headquartered in Zhengzhou, Henan and currently employs 2,084 full-time employees. The firm operates four segments. Pharmaceutical Manufacturing segment is mainly engaged in pharmaceutical preparations and Chinese herbal medicine slices business. Its products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, Xiaoer Qingre Zhike oral liquid, Xiaoer Tuire oral liquid, Danshen oral liquid, Shengmaiyin, Fufang Yimu oral liquid, and various Chinese herbal medicine slices. Pharmaceutical and Medicinal Materials Circulation segment is mainly engaged in fresh processing business and traceable medicinal materials trading. Pharmaceutical Research and Development Services segment mainly provides technical services such as preclinical pharmaceutical research, clinical contract research organization (CRO) research, and registration application. Other segment is mainly engaged in investment business.